Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
:::

洪榮志 (Jung-Jyh Hung)

[簡介]

  • 學歷
    • 國立陽明大學 醫學系 醫學士
    • 國立陽明大學 臨床醫學研究所 博士
  • 經歷
    現職:
    • - 迄今 臺北榮民總醫院 胸腔外科 主治醫師
    • - 迄今 國立陽明大學 醫學系 外科專任教授
    經歷:
    • - 臺北榮民總醫院 外科部 住院醫師
    • - 臺北榮民總醫院 胸腔外科 住院醫師及總醫師
    • - 國泰綜合醫院 胸腔外科 專任主治醫師 
  • 醫療專長
    1. 胸腔鏡微創手術
    2. 肺部毛玻璃病灶
    3. 肺癌
    4. 食道癌
    5. 縱膈腔腫瘤
    6. 肺部轉移癌症
    7. 氣胸、血胸、膿胸
  • 證照
    外科專科醫師 台灣胸腔及心臟血管外科專科醫師 台灣胸腔外科專科醫師 台灣胸腔暨重症加護專科醫師 肺癌專科醫師 重症醫學專科醫師

[著作]

1. Chun-Sung Sung, Tzu-Jung Wei, Jung-Jyh Hung, Fu-Wei Su, Shih-I Ho, Mong-Wei Lin,   Kuang-Cheng Chan, Chun-Yu Wu. Comparisons in analgesic effects between ultrasound-  guided erector spinae plane block and surgical intercostal nerve block after video-  assisted thoracoscopic surgery: A randomized controlled trial. J Clin Anesth. 2024   Aug;95:111448.

2. Tseng YH, Pan SW, Huang JR, Lee CC, Hung JJ, Hsu PK, Chen NJ, Su WJ, Chen YM,   Feng JY. Promoter methylation and increased expression of PD-L1 in patients with   active tuberculosis. Microb Cell. 2024 Jul 29;11:278.

3. Hung JJ,* Kao YS, Huang CH, et al. Overexpression of Aiolos promotes epithelial-  mesenchymal transition and cancer stem cell-like properties in lung cancer cells. Sci   Rep 2019;9:2991. (SCI, IF: 3.998) (*Corresponding author)

4. Lin YH, Hung JJ,* Yeh YC, et al. Prognostic significance of basal versus superior segment   in patients with completely resected lung adenocarcinoma in the lower lobe. Thorac   Cancer 2019;10:312-320. (SCI, IF: 2.610) (*Corresponding author)

5. Hung JJ,* Yeh YC, Hsu WH. Prognostic significance of aldo-keto reductase family 1   member B10 in patients with resected lung adenocarcinoma. Thorac   Cancer 2018;9:1492-1499. (SCI, IF: 2.610) (*Corresponding author)

6.  Hung JJ,* Yeh YC, Wu YC, et al. Prognostic Factors in Completely Resected Node-  negative Lung Adenocarcinoma of 3cm or Smaller. J Thorac Oncol 2017;12:1824-  1833. (SCI, IF: 13.357) (*Corresponding author)

7. Hung JJ, Wu YC, Chou TY, et al. Adjuvant Chemotherapy Improves the Probability of   Freedom from Recurrence in Patients with Resected Stage IB Lung   Adenocarcinoma. Ann Thorac Surg 2016;101:1346-1353. (SCI, IF: 3.639)

8. Hung JJ,* Yeh YC, Jeng WJ, et al. Factors predicting occult lymph node metastasis in   completely resected lung adenocarcinoma of 3cm or smaller. Eur J Cardiothorac   Surg 2016;50:329-336. (SCI, IF 3.486) (*Corresponding author)

9. Hung JJ,* Yeh YC, Jeng WJ, et al. Prognostic Factors of Survival after Recurrence in   Patients with Resected Lung Adenocarcinoma. J Thorac Oncol 2015;10:1328-1336. (SCI,   IF: 13.357) (*Corresponding author)

10. Hung JJ, Yeh YC, Jeng WJ, et al. Predictive Value of the International Association for the   Study of Lung Cancer/American Thoracic Society/European Respiratory Society   Classification of Lung Adenocarcinoma in Tumor Recurrence and Patient Survival. J Clin   Oncol 2014;32:2357-2364. (SCI, IF: 32.956)

11. Hung JJ,* Jeng WJ, Chou TY, et al. Prognostic Value of the New International Association   for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society   Lung Adenocarcinoma Classification on Death and Recurrence in Completely Resected   Stage I Lung Adenocarcinoma. Ann Surg 2013;258:1079-86. (SCI, IF: 10.130)   (*Corresponding author)

12. Liu CY, Hung JJ,* Wang BY, et al. Prognostic factors in resected pathological N1-stage II   nonsmall cell lung cancer. Eur Respir J 2013;41:649-55. (SCI, IF: 12.339) (*Co-first   author)

13. Hung JJ,* Jeng WJ, Hsu WH, et al. Prognostic Significance of the Extent of Visceral   Pleural Invasion in Completely Resected Node-Negative Non-small Cell Lung   Cancer. Chest 2012;142:141-50. (SCI, IF: 8.308) (*Corresponding author)

14. Hung JJ,* Jeng WJ, Hsu WH, et al. Time Trends of Overall Survival and Survival after   Recurrence in Completely Resected Stage I Non-small Cell Lung Cancer. J Thorac   Oncol 2012;7:397-405. (SCI, IF: 13.357) (*Corresponding author)

15. Hung JJ, Jeng WJ, Hsu WH, et al. Predictors of Death, Local Recurrence, and Distant   Metastasis in Completely Resected Pathological Stage-I Non-Small-Cell Lung Cancer. J   Thorac Oncol 2012;7:1115-23. (SCI, IF: 13.357)

16. Hung JJ,* Jeng WJ, Hsu WH, et al. Prognostic factors of post-recurrence survival in   completely resected stage I non-small cell lung cancer with distant   metastasis. Thorax 2010;65:241-5. (SCI, IF: 8.834) (*Corresponding author)

17. Hung JJ, Jeng WJ, Hsu WH, et al. Prognostic factors in pathological stage IB non-small   cell lung cancer greater than 3 cm. Eur Respir J 2010;36:1355-61. (SCI, IF: 12.339)

18. Hung JJ, Hsu WH, Hsieh CC, et al. Post-recurrence survival in completely resected stage I   non-small cell lung cancer with local recurrence. Thorax 2009;64:192-6. (SCI, IF: 8.834)

19. Hung JJ, Yang MH, Hsu HS, et al. Prognostic significance of hypoxia-inducible factor-1a,   TWIST1 and Snail expression in resectable non-small cell lung   cancer. Thorax 2009;64:1082-9. (SCI, IF: 8.834)

20. Hung JJ, Wang CY, Huang MH, et al. Prognostic Factors in Resected Stage I Non-small   Cell Lung Cancer of Diameter 3 cm or Less: Visceral pleural invasion did not influence   overall and disease-free survival. J Thorac Cardiovasc Surg 2007;134:638-43. (SCI, IF:   4.451)

回到最上